v3.26.1
Schedule of consolidated financial statements the related party transactions (Details) - USD ($)
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Total for all related parties [member]      
IfrsStatementLineItems [Line Items]      
Management fee income $ 12,916
Agent commission 13,333 45,590 18,102
Patent License Agreement [1]   707,028
Alps Globemedics Sdn Bhd [member]      
IfrsStatementLineItems [Line Items]      
Agent commission 105,050 196,531 120,189
Management fee income $ 14,185 $ 13,534 $ 12,916
[1] During the financial year ended March 31, 2024, the Company entered into a Patent License Agreement with a director of the Company, wherein the director shall grant to the Company an exclusive, royalty-free and non-transferable right and license all the patents stated in the agreement.